--- title: "Trump Administration to Announce New Biotech Drug Pricing Deals" publication: "MediaBias News" url: "https://mediabias.news/politics/trump-administration-to-announce-new-biotech-drug-pricing-deals" api: "https://mediabias.news/api/v1/stories/trump-administration-to-announce-new-biotech-drug-pricing-deals" markdown: "https://mediabias.news/politics/trump-administration-to-announce-new-biotech-drug-pricing-deals.md" audio: "https://mediabias.news/api/audio/trump-administration-to-announce-new-biotech-drug-pricing-deals" category: "Politics" area: "United States" published: "2026-08-27T02:45:36.328Z" source_reported: "2026-08-27T01:51:00.000Z" updated: "2026-08-27T02:45:36.328Z" trust_score: 42 critic_score: 57 hype_score: 20 assessment_type: "coverage-and-source-reporting-analysis" fact_check_status: "not-performed" coverage_measured: "2026-08-27T02:45:14.274630+00:00" --- # Trump Administration to Announce New Biotech Drug Pricing Deals *Agreements aim to lower outpatient drug costs for state Medicaid programs.* **Scores for the source reporting** (0-100, assessing the original journalism this article was written from, not this write-up): - Trust 42 of 100, higher is better. Central claim attributed to Bloomberg News, with Reuters unable to verify. - Craft 57 of 100, higher is better. Reporting is clear and holds together, but lacks quotes or right of reply. - Hype 20 of 100, lower is better. Language is measured and proportionate, with no sensationalism. Scored by MediaBias News; method at https://mediabias.news/methodology. **The short version** - The Trump administration plans to announce new drug-pricing agreements with midsize biotech companies on Monday. - These agreements will provide discounts on outpatient drugs to state Medicaid programs. - The prices states pay will be aligned with what companies charge in foreign countries. - The administration has previously reached voluntary agreements with 17 pharmaceutical companies. The Trump administration is preparing to announce a new series of drug-pricing agreements with midsize biotech firms on Monday. These deals are intended to offer discounts on outpatient drugs to state Medicaid programs. The pricing structure will ensure that the costs incurred by states are comparable to the prices these companies charge in other countries. ## Disagreements in reporting Reuters stated it could not immediately verify the Bloomberg News report. The Times of India also noted that Reuters could not immediately verify the report. ## What the coverage left out None of the left-rated reports covered this story. The right-rated reports did not mention the specific figure of $64.3 billion in federal and state savings over 10 years that the Times of India reported was expected from the administration's pricing deals. ## Who covered it Shares of the 6 covering outlets with a published leaning rating: - Left: 0% (0) - Centre: 67% (4) - Right: 33% (2) 1 of 7 covering outlets carried no usable leaning rating and were excluded from those percentages. Coverage measured 2026-08-27T02:45:14.274630+00:00. **Coverage watch:** developing. Checked 2 times; 0 checks found a material change. Most recently checked 2026-08-27T03:15:17.439Z. ## How the sides framed it ### Left No separate framing summary. ### Centre - The centre-rated reports led with the White House's plan to announce new drug pricing deals with biotechs. They specified that the announcement was planned for Monday and cited Bloomberg News as the source of the report. These digests noted that the agreements would involve midsize biotech companies and that the administration had previously reached similar deals with other pharmaceutical companies. ### Right - The right-rated reports highlighted the Trump administration's intention to announce new drug pricing deals with biotechs. The Times of India, which provided a full report, also mentioned that these agreements would involve discounts on outpatient drugs for state Medicaid programs, aligning prices with those in foreign countries. It noted that the administration had previously secured voluntary agreements with 17 pharmaceutical companies and that US patients pay significantly more for prescription medicines than in other developed nations. The Times of India also included information about expected federal and state savings from these pricing deals. **Provisional coverage gap:** left. The watch is not closed, so this is not yet a settled blindspot finding. ## Factuality profile of the covering outlets These are published factuality ratings of the outlets, not a verdict on whether this story or its claims are true. - mixed: 2 - high: 2 - unknown: 1 - veryHigh: 2 ## Verification scope This page compares coverage and scores the source reporting. It is not a ClaimReview verdict on whether the underlying event or claim is true. ## Original reporting this was written from - [Times of India](https://economictimes.indiatimes.com/news/international/world-news/white-house-to-announce-new-drug-pricing-deals-with-biotechs-report/articleshow/133553887.cms) — White House to announce new drug pricing deals with biotechs: Report - [Bloomberg](https://bloomberg.com/news/articles/2026-08-26/white-house-to-announce-new-drug-pricing-deals-with-biotechs) — White House to Announce New Drug Pricing Deals With Biotechs - [Investing.com](https://investing.com/news/world-news/white-house-to-announce-new-drug-pricing-deals-with-biotechs-bloomberg-news-reports-4877661) — White House to announce new drug pricing deals with biotechs, Bloomberg News reports - [Reuters](https://reuters.com/world/white-house-announce-new-drug-pricing-deals-with-biotechs-bloomberg-news-reports-2026-08-26) — White House to announce new drug pricing deals with biotechs, Bloomberg News reports - [WTVB](https://wtvbam.com/2026/08/26/white-house-to-announce-new-drug-pricing-deals-with-biotechs-bloomberg-news-reports) — White House to announce new drug pricing deals with biotechs, Bloomberg News reports - [Seeking Alpha](https://seekingalpha.com/news/4637100-white-house-announce-drug-pricing-deals-with-biotechs) — White House to announce drug pricing deals with biotechs - [taylorvilledailynews.com](https://taylorvilledailynews.com/white-house-to-announce-new-drug-pricing-deals-with-biotechs-bloomberg-news-reports) — White House to announce new drug pricing deals with biotechs, Bloomberg News reports - Taylorville Daily News ## Questions **What is the Trump administration announcing?** The Trump administration is planning to announce new drug-pricing agreements with midsize biotech companies on Monday. These agreements are designed to provide discounts on outpatient drugs for state Medicaid programs. **How will the new drug prices be determined?** The prices that state Medicaid programs will pay for outpatient drugs will be aligned with the prices that the biotech companies charge in foreign countries, according to the reports. **Has the administration made similar deals before?** Yes, the Trump administration has previously reached voluntary agreements with 17 pharmaceutical companies to lower medicine prices for government programs and cash payers. --- MediaBias News — https://mediabias.news. Reproduced from https://mediabias.news/politics/trump-administration-to-announce-new-biotech-drug-pricing-deals. Please cite as: MediaBias News, "Trump Administration to Announce New Biotech Drug Pricing Deals", https://mediabias.news/politics/trump-administration-to-announce-new-biotech-drug-pricing-deals